Effectiveness of BNT162b2 Vaccine Against Omicron-SARSCoV- 2 Subvariants in Children 5-11 Years of Age in Quebec, Canada, January 2022 to January 2023.
- Resource Type
- Article
- Source
- Pediatric Infectious Disease Journal; Jan2024, Vol. 43 Issue 1, p32-39, 8p
- Subject
- Language
- ISSN
- 08913668